PRODUCT & GENERIC
|
STRENGTH & PHOTO
|
ATC CLASS
|
MIMS CLASS
|
Aldurazyme infusion
(laronidase)
| Infusion : 2.9 mg/5 mL x 1's
| Enzymes | Other Agents Affecting Metabolism (11g) |
Cerezyme vial
(imiglucerase)
| Vial : 200 u x 1's , 400 u x 1's
200 u
| Enzymes | Other Agents Affecting Metabolism (11g) |
Fabrazyme vial
(agalsidase beta)
| Vial : 5 mg x 1's , 35 mg x 1's
5 mg
| Enzymes | Other Agents Affecting Metabolism (11g) |
Fludara vial
(fludarabine phosphate)
| Vial : 50 mg x 5's
50 mg
| Purine analogues | Cytotoxic Chemotherapy (9a) |
Fludara film-coated tab
(fludarabine phosphate)
| Film-coated tab : 10 mg x 5's , 10 mg x 15's , 10 mg x 20's
10 mg
| Purine analogues | Cytotoxic Chemotherapy (9a) |
MabCampath vial
(alemtuzumab)
| Vial : 30 mg/1 mL x 1 mL x 3's
30 mg/1 mL
| Monoclonal antibodies | Targeted Cancer Therapy (9d) |
Myozyme vial
(alglucosidase alfa)
| Vial : 50 mg x 1's
50 mg
| Enzymes | Intravenous & Other Sterile Solutions (20) |
Seprafilm adhesion barrier patch
(carboxymethylcellulose, sodium hyaluronate)
| Adhesion barrier patch : 1's
| ALL OTHER NON-THERAPEUTIC PRODUCTS | Miscellaneous (21) |
Synvisc syringe
(hylan G-F 20)
| Syringe : 8 mg/1 mL x 2 mL x 3's
8 mg/1 mL
| Other drugs for disorders of the musculo-skeletal system | Other Drugs Acting on Musculo-Skeletal System (5f) |
Synvisc One syringe
(hylan G-F 20)
| Syringe : 8 mg/1 mL x 6 mL x 1's
8 mg/1 mL
| Other drugs for disorders of the musculo-skeletal system | Other Drugs Acting on Musculo-Skeletal System (5f) |
Thymoglobuline vial
(antithymocyte immunoglobulin (rabbit), human)
| Vial : 5 mg/1 mL x 5 mL x 1's
5 mg/1 mL
| Selective immunosuppressants | Immunosuppressants (18c) |
Thyrogen vial
(thyrotropin alfa)
| Vial : 1.1 mg x 2's
1.1 mg
| Tests for thyreoidea function | Trophic Hormones & Related Synthetic Drugs (6e) |